208 related articles for article (PubMed ID: 11850153)
1. The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain.
Reneman L; Endert E; de Bruin K; Lavalaye J; Feenstra MG; de Wolff FA; Booij J
Neuropsychopharmacology; 2002 Mar; 26(3):387-96. PubMed ID: 11850153
[TBL] [Abstract][Full Text] [Related]
2. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.
Reneman L; Booij J; Schmand B; van den Brink W; Gunning B
Psychopharmacology (Berl); 2000 Feb; 148(3):322-4. PubMed ID: 10755746
[TBL] [Abstract][Full Text] [Related]
3. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings.
Reneman L; Habraken JB; Majoie CB; Booij J; den Heeten GJ
AJNR Am J Neuroradiol; 2000; 21(6):1001-7. PubMed ID: 10871002
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].
Ross JD; Herin DV; Frankel PS; Thomas ML; Cunningham KA
Drug Alcohol Depend; 2006 Feb; 81(2):117-27. PubMed ID: 16054778
[TBL] [Abstract][Full Text] [Related]
5. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.
Reneman L; Lavalaye J; Schmand B; de Wolff FA; van den Brink W; den Heeten GJ; Booij J
Arch Gen Psychiatry; 2001 Oct; 58(10):901-6. PubMed ID: 11576026
[TBL] [Abstract][Full Text] [Related]
6. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
Kramer HK; Poblete JC; Azmitia EC
Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
[TBL] [Abstract][Full Text] [Related]
7. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.
Di Iorio CR; Watkins TJ; Dietrich MS; Cao A; Blackford JU; Rogers B; Ansari MS; Baldwin RM; Li R; Kessler RM; Salomon RM; Benningfield M; Cowan RL
Arch Gen Psychiatry; 2012 Apr; 69(4):399-409. PubMed ID: 22147810
[TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
[TBL] [Abstract][Full Text] [Related]
9. Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
Urban NB; Girgis RR; Talbot PS; Kegeles LS; Xu X; Frankle WG; Hart CL; Slifstein M; Abi-Dargham A; Laruelle M
Neuropsychopharmacology; 2012 May; 37(6):1465-73. PubMed ID: 22353758
[TBL] [Abstract][Full Text] [Related]
10. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
11. Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.
Capela JP; Fernandes E; Remião F; Bastos ML; Meisel A; Carvalho F
Neurotoxicology; 2007 Jul; 28(4):868-75. PubMed ID: 17572501
[TBL] [Abstract][Full Text] [Related]
12. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
Reneman L; Booij J; de Bruin K; Reitsma JB; de Wolff FA; Gunning WB; den Heeten GJ; van den Brink W
Lancet; 2001 Dec; 358(9296):1864-9. PubMed ID: 11741626
[TBL] [Abstract][Full Text] [Related]
13. Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
Audenaert K; Van Laere K; Dumont F; Vervaet M; Goethals I; Slegers G; Mertens J; van Heeringen C; Dierckx RA
J Nucl Med; 2003 Feb; 44(2):163-9. PubMed ID: 12571204
[TBL] [Abstract][Full Text] [Related]
14. Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.
McGregor IS; Clemens KJ; Van der Plasse G; Li KM; Hunt GE; Chen F; Lawrence AJ
Neuropsychopharmacology; 2003 Aug; 28(8):1472-84. PubMed ID: 12700695
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
Kramer HK; Poblete JC; Azmitia EC
Neuropsychopharmacology; 1998 Oct; 19(4):265-77. PubMed ID: 9718590
[TBL] [Abstract][Full Text] [Related]
16. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.
Liechti ME; Saur MR; Gamma A; Hell D; Vollenweider FX
Neuropsychopharmacology; 2000 Oct; 23(4):396-404. PubMed ID: 10989266
[TBL] [Abstract][Full Text] [Related]
17. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
18. Repeated adolescent MDMA ("Ecstasy") exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist.
Biezonski DK; Courtemanche AB; Hong SB; Piper BJ; Meyer JS
Brain Res; 2009 Feb; 1252():87-93. PubMed ID: 19059385
[TBL] [Abstract][Full Text] [Related]
19. MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low- but not high-aggressive rats.
Wallinga AE; ten Voorde AM; de Boer SF; Koolhaas JM; Buwalda B
Eur J Pharmacol; 2009 Sep; 618(1-3):22-7. PubMed ID: 19616536
[TBL] [Abstract][Full Text] [Related]
20. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
Morley KC; Arnold JC; McGregor IS
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
